{
    "clinical_study": {
        "@rank": "97350", 
        "arm_group": [
            {
                "arm_group_label": "Mate extracts group", 
                "arm_group_type": "Experimental", 
                "description": "Mate extract(3150 mg/day)for 12 weeks"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo (3150 mg/day) for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Obesity is a major health issue worldwide; there is a constant raise in obesity related\n      death each year."
        }, 
        "brief_title": "Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "detailed_description": {
            "textblock": "The primary aim of the study was to investigate the effect of Mate extracts in Korean\n      subjects on body fat and abdominal fat, double blind, placebo-controlled clinical trial.\n\n      Thirty obesity subjects with BMI \u2265 25 kg/\u33a1 and waist-hip ratio (WHR)\u2265 0.90 for men and \u2265\n      0.85 for women were for 12 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Volunteers aged 19 to 65 years\n\n          -  25 kg/m2 \u2264 BMI \u226535 kg/m2\n\n          -  Ability to give informed consent\n\n        Exclusion Criteria:\n\n          -  Significant variation in weight (more 10%) in the past 3 month\n\n          -  Cardiovascular disease, neurologic or psychiatric disease, renal, pulmonary and\n             hepatic abnormalities\n\n          -  History of disease that could interfere with the test products or impede their\n             absorption, such as gastrointestinal disease (Crohn's disease) or gastrointestinal\n             surgery (a caesum or enterocele surgery are included)\n\n          -  Laboratory test, medical or psychological conditions deemed by the investigators to\n             interfere with successful participation in the sutdy\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products\n\n          -  Pregnancy or breast feeding\n\n          -  Used antipsychosis drugs therapy within past 2 months\n\n          -  History of alcohol or substance abuse (21 units/week over)\n\n          -  Participation in any other clinical trials within past 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778257", 
            "org_study_id": "CUH_2011_GS_MATE"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mate extracts group", 
                "description": "Mate is a South American herb that is traditionally prepared as a tea and used, among others, for weight reduction.", 
                "intervention_name": "Mate extract", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Extracts of Ilex paraguariensis A. St.-Hil."
            }, 
            {
                "arm_group_label": "Placebo group", 
                "description": "Amount and calorie of placebo are same with Mate extracts.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Placebo"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mate extracts", 
            "Obesity", 
            "abdominal fat"
        ], 
        "lastchanged_date": "January 25, 2013", 
        "number_of_arms": "2", 
        "official_title": "Mate Extract Supplementation Reduces Body and Abdominal Fat in Obese Korean Subjects", 
        "overall_official": {
            "affiliation": "Chonbuk National University Hospital", 
            "last_name": "Min-Gul Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes in body and abdominal fat", 
            "safety_issue": "Yes", 
            "time_frame": "body fat: baseline, 6 weeks and 12 weeks, abdominal fat of CT: baseline and 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778257"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Min-Gul Kim, MD", 
            "investigator_title": "Clinical Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Changes in anthropometric parameters(weight, BMI, waist and hip circumference)", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, 6 weeks and 12 weeks"
            }, 
            {
                "measure": "Changes in blood lipid profile(total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, free fatty acid)", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, 6 weeks and 12 weeks"
            }
        ], 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "GS Engineering & Construction", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}